₹161.96
▲ +3.95 +2.50%
17 Jul 2026
NSE Listed
Arvee Laboratories I Ltd. (ARVEE)
20-day avg volume: 2K shares
- Company is almost debt-free.
- Revenue fell 13% YoY.
- Stock trades at a high P/E of 336.
| Metric | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹11 Cr | ₹13 Cr | ₹9 Cr | ₹6 Cr | ₹7 Cr | ₹3 Cr | ₹10 Cr | ₹11 Cr |
| EBITDA | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹1 Cr |
| Net Profit | ₹1 Cr | ₹1 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹1 Cr |
| EPS | — | — | — | — | — | — | — | — |
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹48 Cr | ₹55 Cr | ₹46 Cr | ₹48 Cr | ₹41 Cr | ₹63 Cr | ₹31 Cr | ₹39 Cr |
| EBITDA | ₹5 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹7 Cr | ₹2 Cr | ₹3 Cr |
| Net Profit | ₹1 Cr | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹1 Cr | ₹2 Cr |
| EPS | 2.58 | 4.11 | 4.17 | 2.43 | 2.34 | 3.74 | 0.95 | 1.95 |
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹44 Cr | ₹37 Cr | ₹34 Cr | ₹41 Cr | ₹39 Cr | ₹39 Cr | ₹38 Cr | ₹38 Cr |
| Total Liabilities | ₹30 Cr | ₹21 Cr | ₹15 Cr | ₹20 Cr | ₹15 Cr | ₹11 Cr | ₹9 Cr | ₹6 Cr |
| Equity | ₹14 Cr | ₹16 Cr | ₹19 Cr | ₹21 Cr | ₹24 Cr | ₹28 Cr | ₹29 Cr | ₹31 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹3 Cr | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹0 Cr |
| Investing | ₹-1 Cr | ₹0 Cr | ₹-1 Cr | ₹-2 Cr | ₹-1 Cr |
| Financing | ₹5 Cr | ₹-6 Cr | ₹-2 Cr | ₹0 Cr | ₹0 Cr |
| Free Cash Flow | ₹3 Cr | ₹2 Cr | ₹5 Cr | ₹4 Cr | ₹0 Cr |
Basic Materials · Specialty Chemicals
Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
arveelabs.com ↗As of 2026-03-31
Quarterly — figures in %. Latest 12 quarters.
| Period | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% | 73.5% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% | 26.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 893 | 905 | 1,372 | 1,298 | 1,480 | 1,416 | 1,623 | 1,576 | 1,505 | 1,505 | 1,861 | 1,638 |
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
| Name | Category | Stake | Shares |
|---|---|---|---|
| Shalin Sudhakarbhai Patel | Shareholding of Promoter and Promoter Group | 36.7% | 40,42,000 |
| Mitaben Bharatbhai Chokshi | Shareholding of Promoter and Promoter Group | 24.6% | 27,08,000 |
| Kavita Shalin Chokshi | Shareholding of Promoter and Promoter Group | 12.2% | 13,40,000 |
| Gitaben Dinehsbhai Patel | Public Shareholding | 10% | 11,00,000 |
| Deval Pranav Patel | Public Shareholding | 5.2% | 5,72,000 |
| Jashbhai Patel | Public Shareholding | 4.8% | 5,28,000 |
| Madhuben Jashbhai Patel | Public Shareholding | 3.7% | 4,08,000 |
| Khushbuben Shalinbhai Patel | Shareholding of Promoter and Promoter Group | 0% | 2,000 |
| Sudhakar Chhotabhai Patel Huf | Shareholding of Promoter and Promoter Group | 0% | 2,000 |
| Shalinbhai Sudhakarbhai Patel Huf | Shareholding of Promoter and Promoter Group | 0% | 2,000 |
| Chandrabalaben Patel | Shareholding of Promoter and Promoter Group | 0% | 2,000 |
| Forum Saumil Chokshi | Shareholding of Promoter and Promoter Group | 0% | 2,000 |
| Bharat Rasiklal Chokshi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Saumil Bharatbhai Chokshi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Dhaval Sunilbhai Thakkar | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Veer Shalin Patel | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Shalin Bharatbhai Chokshi | Shareholding of Promoter and Promoter Group | 0% | 0 |
| Holder | Pledged Shares | % of Holding | As of |
|---|---|---|---|
| Shalin Sudhakarbhai Patel | 0 | 0% | 2026-03-31 |
| Mitaben Bharatbhai Chokshi | 0 | 0% | 2026-03-31 |
| Shalin Bharatbhai Chokshi | 0 | 0% | 2026-03-31 |
| Sudhakar Chhotabhai Patel Huf | 0 | 0% | 2026-03-31 |
| Shalinbhai Sudhakarbhai Patel Huf | 0 | 0% | 2026-03-31 |
| Chandrabalaben Patel | 0 | 0% | 2026-03-31 |
| Forum Saumil Chokshi | 0 | 0% | 2026-03-31 |
| Kavita Shalin Chokshi | 0 | 0% | 2026-03-31 |
| Khushbuben Shalinbhai Patel | 0 | 0% | 2026-03-31 |
| Bharat Rasiklal Chokshi | 0 | 0% | 2026-03-31 |
| Saumil Bharatbhai Chokshi | 0 | 0% | 2026-03-31 |
| Dhaval Sunilbhai Thakkar | 0 | 0% | 2026-03-31 |
| Name | Designation | Year |
|---|---|---|
| Shalin Sudhakarbhai Patel | Chairman & Managing Director | 2020 |
| Shalin Bharat Chokshi | Whole-time Director | 2020 |
| Chandrakala Ashok Bhatt | Independent Director | 2020 |
| Vishal Nitin Mehta | Independent Director | 2020 |
| Amishkumar Maheshkumar Shah | Independent Director | 2020 |
| Paragbhai Manubhai Shah | Independent Director | 2020 |
| Neetu Jalan | Independent Director | 2020 |
| SACHIN KANWARLAL KANSAL | Independent Director | 2020 |
| Region | Revenue | Share |
|---|---|---|
| Domestic Sales | ₹32 Cr | 82.7% |
| Export Sales | ₹7 Cr | 17.3% |
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 11 | 11 | 11 |
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 3 | 0 | 1 | 0 | 7 |
| 2025 | 0 | 1 | 0 | 0 | 0 | 2 |
| 2025 | 0 | 2 | 0 | 1 | 0 | 4 |
📍 49/3 B Shyamal Row House, 100 Feet Road Satelitte, Ahmedabad, Gujarat, 380015
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search